MTOR and neoplasm: Somatostatin analogs: lanreotide or octreotide for symptom control and tumor stabilization. Targeted therapy: Everolimus (mTOR inhibitor) or sunitinib (tyrosine kinase inhibitor). Chemotherapy: etoposide and platinum-based agents for aggressive tumors.